Neurobiology of Aging
Volume 27, Issue 12 , Pages 1769-1785 , December 2006

Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia

  • Gustavo C. Román

      Affiliations

    • University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA
    • ,
  • Raj N. Kalaria

      Affiliations

    • University of Newcastle upon Tyne, Wolfson Research Centre, Institute for Aging and Health, Newcastle General Hospital, Westgate Road, Newcastle, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 191 256 3305/444 4401; fax: +44 191 444 4402.

Received 11 March 2005 ,Revised 2 September 2005 ,Accepted 3 October 2005.

References 

  1. Allen SJ, Dawbarn D, Wilcock GK. Morphometric immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer's disease. Brain Res. 1988;454:275–281
  2. Alonso JR, Amaral DG. Cholinergic innervation of the primate hippocampal formation: I. Distribution of choline acetyltransferase immunoreactivity in the Macaca fascicularis and Macaca mulatta monkeys. J Comp Neurol. 1995;355:135–170
  3. Alonso UHS, Amaral DG. Cholinergic innervation of the primate hippocampal formation: II. Effects of fimbria/fornixtransection. J Comp Neurol. 1996;375:527–551
  4. Arciniegas D, Adler L, Topkoff J, Cawthra E, Filley CM, Reite M. Attention and memory dysfunction after traumatic brain injury: cholinergic mechanisms, sensory gating, and a hypothesis for further investigation. Brain Inj. 1999;13:1–13
  5. Barrett AM. Pre-senile arteriosclerotic and senile disorders of the brain and cord. In:  White WA,  Jellife SE editor. The modern treatment of nervous and mental diseases. London: Henry Kimpton; 1913;p. 675–709
  6. Bartus RT, Johnson HR. Short-term memory in the rhesus monkey: disruption from the anti-cholinergicscopolamine. Pharmacol Biochem Behav. 1976;5:39–46
  7. Bartus RT. On neurodegenerative diseases, models and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol. 2000;163:495–529
  8. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005;64:834–841
  9. Bertrand N, Ishii H, Spatz M. Cerebral ischemia in young and adult gerbils: effects on cholinergic metabolism. Neurochem Int. 1996;28:293–297
  10. Bierer LM, Haroutunian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, et al. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem. 1995;64:749–760
  11. Biesold D, Inanami O, Sato A, Sato Y. Stimulation of the nucleus basalis of Meynert increases cerebral cortical blood flow in rats. Neurosci Lett. 1989;98:39–44
  12. Bigl V, Arendt T, Fischer S, Fischer S, Werner M, Arendt A. The cholinergic system in aging. Gerontology. 1987;33:172–180
  13. Black S, Román GC, Geldmacher DS, Salloway S, Hecker J, Burns A, et al. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke. 2003;34:2323–2330
  14. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114:797–811
  15. Blin J, Ivanoiu A, Coppens A, De Voider A, Labar D, Michel C, et al. Cholinergic neurotransmission has different effects on cerebral glucose consumption and blood flow in young normals, aged normals, and Alzheimer's disease patients. Neuroimage. 1997;6:335–343
  16. Borlongan CV, Cahill DW, Sanberg PR. Locomotor and passive avoidance deficits following occlusion of the middle cerebral artery. Physiol Behav. 1995;58:909–917
  17. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl). 1991;82:239–259
  18. Braak H, Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging. 1995;16:271–278
  19. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol. 1986;19:253–262
  20. Butcher LL, Semba K. Reassessing the cholinergic basal forebrain: nomenclature schemata and concepts. Trends Neurosci. 1989;12:483–485
  21. Cannata AP, Alberoni M, Franceschi M, Mariani C. Frontal impairment in subcortical ischemic vascular dementia in comparison to Alzheimer's disease. Dement Geriatr Cogn Disord. 2002;13:101–111
  22. Cauli B, Tong XK, Rancillac A, Serluca N, Lambolez B, Rossier J, et al. Cortical GABA interneurons in neurovascular coupling: relays for subcortical vasoactive pathways. J Neurosci. 2004;24:8940–8949
  23. Charcot JM, Bouchard C. Nouvelles recherches sur la pathogenie de I’hémorrhagie cérébrale. Archives de Physiologie Normale et Pathologique (Paris). 1868;1:110–127
  24. Chen CP. Transcultural expression of subcortical vascular disease. J Neurol Sci. 2004;226:45–47
  25. Chukwudelunzu FE, Meschia JF, Graff-Radford NR, Lucas JA. Extensive metabolic and neuropsychological abnormalities associated with discrete infarction of the genu of the internal capsule. J Neural Neurosurg Psychiatry. 2001;71:658–662
  26. Cole FM, Yates P. Intracerebral microaneurysms and small cerebrovascular lesions. Brain. 1967;90:759–768
  27. Conner JM, Darracq MA, Roberts J, Tuszynski MH. Nontropic actions of neurotrophins: subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation. Proc Natl Acad Sci USA. 2001;98:1941–1946
  28. Corey-Bloom J, Sabbagh MN, Bondi MW, Hansen L, Alford MF, Masliah E, et al. Hippocampal sclerosis contributes to dementia in the elderly. Neurology. 1997;48:154–160
  29. Counts SE, Mufson EJ. The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. J Neuropathol Exp Neural. 2005;64:263–272
  30. Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, et al. AD2000 Collaborative Group Lancet. 2004;363:2105–2115
  31. Coutard M, Huang W, Osborne-Pellegrin M. Heritability of intracerebral hemorrhagic lesions and cerebral aneurysms in the rat. Stroke. 2000;321:2678–2684
  32. Cruveilhier J. Anatomie pathologique du corps humain, vol. 1. Paris: JB Baillière; 1833;pp. 1829–1842
  33. Cummings JL. The role of cholinergic agents in the management of behavioural disturbances in Alzheimer's disease. Int J Neuropsychopharmacol. 2000;3:21–29
  34. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol. 1999;58:376–388
  35. Davis KL, Mohs RC, Marin D, Purohit DP, Lantz M, Austin G, et al. Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA. 1999;281:1401–1406
  36. DeCarli C. Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurol. 2003;2:15–21
  37. Decker MW, Brioni JD, Sullivan JP, Buckley MJ, Radek RJ, Raszkiewicz JL, et al. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization. J Pharmacol Exp Ther. 1994;270:319–328
  38. DeKosky ST, Ikonomovic MD, Styren SD, Beckett L, Wisniewski S, Bennett DA, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol. 2002;51:145–155
  39. Delay J, Brion S. Les démences tardives. Paris: Masson; 1962;
  40. Dening TR, Berrios GE. The vascular dementias. In:  Berrios GE,  Freeman HL,  L’Etang H editor. Alzheimer and the dementias. London: Royal Society of Medical Services Ltd.; 1991;p. 69–76
  41. Desmond DW, Erkinjuntti T, Sano M, Cummings JL, Bowler JV, Pasquier F, et al. The cognitive syndrome of vascular dementia: implications for clinical trials. Alzheimer Dis Assoc Disord. 1999;13:S21–S29
  42. Desmond DW. Vascular dementia: a construct in evolution. Cerebrovasc Brain Metab Rev. 1996;8:296–325
  43. Dickson DW, Davies P, Bevona C, Van Hoeven KH, Factor SM, Grober E, et al. Hippocampal sclerosis: a common pathological feature of dementia in very old (≥80 years of age) humans. Acta Neuropathol (Berl). 1994;88:212–221
  44. Domino EF, Minoshima S, Guthrie S, Ohl L, Ni L, Koeppe RA, et al. Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse. 2000;38:313–321
  45. Dubelaar EJ, Verwer RW, Hofman MA, Van Heerikhuize JJ, Ravid R, Swaab DE. ApoE epsilon4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatus. J Neuropathol Exp Neurol. 2004;63:159–169
  46. Dubois MF, Hebert R. The incidence of vascular dementia in Canada: a comparison with Europe and East Asia. Neuroepidemiology. 2001;20:179–187
  47. Dupont S. The anatomy of episodic memory: evolution of concepts. Morphologie. 2003;87:5–9
  48. Englund E, Brun A, Ailing C. White matter changes in dementia of Alzheimer's type: biochemical and neuropathological correlates. Brain. 1988;111:1425–1439
  49. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet. 2002;359:1283–1290
  50. Erkinjuntti T, Román GC, Gauthier S, Feldman H, Rockwood K. Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke. 2004;35:1010–1017
  51. Everitt BJ, Robbins TW. Central cholinergic systems and cognition. Annu Rev Psychol. 1997;48:649–684
  52. Feigin VL, Lawes CMM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2:43–53
  53. Fernando MS, Ince PG MRC Cognitive Function and Ageing Neuropathology Study Group. Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci. 2004;226:13–17
  54. Ferrand J. Essay sur I’hémiplégie des vieillards. Les lacunes de désintégration cérébrale. Paris: Rousset Editeurs; 1902;
  55. Ferrari R, Frasoldati A, Leo G, Torri C, Zini I, Agnati LF, et al. Changes in nicotinic acetylcholine receptor subunit mRNAs and nicotinic binding in spontaneously hypertensive stroke prone rats. Neurosci Lett. 1999;277:169–172
  56. Fisher CM. Cerebral miliary aneurysms in hypertension. Am J Pathol. 1972;66:313–330
  57. Fisher CM. Lacunes: small, deep cerebral infarcts. Neurology. 1965;15:774–784
  58. Fox NC, Warrington EK, Seiffer AL, Agnew SK, Rossor MN. Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study. Brain. 1998;121:1631–1639
  59. Garrard P, Perry R, Hodges JR. Disorders of semantic memory. J Neurol Neurosurg Psychiatry. 1997;62:431–435
  60. Ghika JA, Bogousslavsky J, Regli F. Deep perforators from the carotid system. Template of the vascular territories. Arch Neurol. 1990;47:1097–1100
  61. Gilmor ML, Erickson JD, Varoqui H, Hersh LB, Bennett DA, Cochran EJ, et al. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 1999;411:693–704
  62. Gold G, Bouras C, Canuto A, Bergallo MF, Herrmann FR, Hof PR, et al. Clinicopathological validation study of four sets of clinical criteria for vascular dementia. Am J Psychiatry. 2002;159:82–87
  63. Gomes FB, Dujovny M, Umansky F, Berman SK, Diaz FG, Ausman JI, et al. Microanatomy of the anterior cerebral artery. Surg Neurol. 1986;26:129–141
  64. Gottfries CG, Blennow K, Karlsson I, Wallin A. The neurochemistry of vascular dementia. Dementia. 1994;5:163–167
  65. Goulding JM, Signorini DF, Chatterjee S, Nicoll JA, Stewart J, Morris R, et al. Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia. J Neurol Neurosurg Psychiatry. 1999;67:654–657
  66. Grutzendler J, Morris JC. Cholinesterase inhibitors for Alzheimer's disease. Drugs. 2001;61:41–52
  67. Gsell W, De Sadeleer C, Marchalant Y, MacKenzie ET, Schumann PT, Dauphin F, et al. The use of cerebral blood flow as an index of neuronal activity in functional neuroimaging: experimental and pathophysiological considerations. J Chem Neuroanat. 2000;20:215–224
  68. Hachinski VC, IIiff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, et al. Cerebral blood flow in dementia. Arch Neurol. 1975;32:632–637
  69. Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet. 1974;2:207–210
  70. Halliday GM, Cullen K, Cairns MJ. Quantitation and three-dimensional reconstruction of Ch4 nucleus in the human basal forebrain. Synapse. 1993;15:1–16
  71. Hamel E. Cholinergic modulation of the cortical microvascular bed. Prog Brain Res. 2004;145:171–178
  72. Hanyu H, Asano T, Sakurai H, Tanaka Y, Takasaki M, Abe K. MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. Am J Neuroradiol. 2002;23:27–32
  73. Hedreen JC, Struble RG, Whitehouse PJ, Price DL. Topography of the magnocellular basal forebrain system in human brain. J Neuropathol Exp Neurol. 1984;43:1–21
  74. Hefti F, Hartikka J, Salvatierra A, Weiner WJ, Mash DC. Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain. Neurosci Lett. 1986;69:37–41
  75. Hénon H, Durieu I, Guerouaou D, Lebert F, Pasquier F, Leys D. Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology. 2001;57:1216–1222
  76. Hénon H, Pasquier F, Durieu I, Godefroy O, Lucas C, Lebert F, et al. Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. Stroke. 1997;28:2429–2436
  77. Herholz K, Bauer B, Wienhard K, Kracht L, Mielke R, Lenz MO, et al. In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism. J Neural Transm. 2000;107:1457–1468
  78. Hodges J. The amnestic prodrome of Alzheimer's disease. Brain. 1998;121:1601–1602
  79. Horikoshi T, Akiyama I, Yamagata Z, Sugita M, Nukui H. Magnetic resonance angiographic evidence of sex-linked variations in the circle of Willis and the occurrence of cerebral aneurysms. J Neurosurg. 2002;96:697–703
  80. Hughes W. Origin of lacunes. Lancet. 1965;2:19–21
  81. Hulette CM, Welsh-Bohmer KA, Murray MG, Saunders AM, Mash DC, Mclntyre LM. Neuropathological and neuropsychological changes in “normal” aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol. 1998;57:1168–1174
  82. Ikeda M, Hokoishi K, Maki N, Nebu A, Tachibana N, Komori K, et al. Increased prevalence of vascular dementia in Japan: a community-based epidemiological study. Neurology. 2001;57:839–844
  83. lljin K, Petrova TV, Veikkola T, Kumar V, Poutanen M, Alitalo K. A fluorescent Tie1 reporter allows monitoring of vascular development and endothelial cell isolation from transgenic mouse embryos. FASEB J. 2002;16:1764–1774
  84. Inglis WL, Winn P. The pedunculopontine tegmental nucleus: where the striatum meets the reticuIar formation. Prog Neurobiol. 1995;47:1–29
  85. Ishimaru H, Takahashi A, Ikarashi Y, Maruyama Y. Immunohistochemical and neurochemical studies of hippocampal cholinergic neurons after ischemia. Neuroreport. 1995;6:557–560
  86. Iwasaki K, Kitamura Y, Ohgami Y, Mishima K, Fujiwara M. The disruption of spatial cognition and changes in brain amino acid, monoamine and acetylcholine in rats with transient cerebral ischemia. Brain Res. 1996;709:163–172
  87. Jellinger KA, Attems J. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J Neurol Sci. 2005;229–230:37–41
  88. Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord. 1999;13(Suppl. 3):S115–S123
  89. In:  Kalaria RN,  Ince P editor. Vascular factors in Alzheimer's disease (Annals of the New York Academy of Sciences). vol. 903:New York: New York Academy of Sciences; 2000;
  90. Kalaria RN, Ballard CG, Ince PG, Kenny RA, McKeith I, Morris CM, et al. Multiple substrates of late-onset dementia: implications for brain protection. In:  Foundation N editors. Ageing vulnerability: causes and intervention. Chichester: John Wiley & Sons Limited; 2001;p. 49–65
  91. Kalaria RN. Advances in molecular genetics and pathology of cerebrovascular disorders. Trends Neurosci. 2001;24:392–400
  92. Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci. 2004;226:75–80
  93. Kalimo H, Ruchoux MM, Viitanen M, Kalaria RN. CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol. 2002;12:371–384
  94. Kayembe KN, Sasahara M, Hazama F. Cerebral aneurysms and variations in the circle of Willis. Stroke. 1984;15:846–850
  95. Keverne JS, Court JA, Piggott M, Ince PG, Kalaria RN. Cholinergic neurons and microvascular pathology in dementia. British Neurosci Assoc. 2003;17:78;[Abstract]
  96. Kimura S, Saito H, Minami M, Togashi H, Nakamura N, Nemoto M, et al. Pathogenesis of vascular dementia in stroke-prone spontaneously hypertensive rats. Toxicology. 2000;153:167–178
  97. Knopman DS, Parisi JE, Boeve BF, Cha RH, Apaydin H, Salviati A, et al. Vascular dementia in a population-based autopsy study. Arch Neurol. 2003;60:569–575
  98. Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik RJ, et al. Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol. 2003;62:1087–1095
  99. Kovari E, Gold G, Herrmann FR, Canuto A, Hof PR, Michel JP, et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke. 2004;35:410–414
  100. Kumar V, Anand R, Messina J, Hartman R, Veach J. An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors. Eur J Neurol. 2000;7:159–169
  101. Lacombe P, Sercombe R, Vaucher E, Seylaz J. Reduced cortical vasodilatory response to stimulation of the nucleus basalis of Meynert in the aged rat and evidence for a control of the cerebral circulation. Ann N Y Acad Sci. 1997;826:410–415
  102. Lawson ND, Weinstein BM. Arteries and veins: making a difference with zebrafish. Nat Rev Genet. 2002;3:624–682
  103. Liberini P, Pioro EP, Maysinger D, Cuello AC. Neocortical infarction in subhuman primates leads to restricted morphological damage of the cholinergic neurons in the nucleus basalis of Meynert. Brain Res. 1994;648:1–8
  104. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, et al. Neurologic Diseases in the Elderly Research Group Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology. 2000;54(11 Suppl. 5):S4–S9
  105. Lojkowska W, Ryglewicz D, Jedrzejczak T, Mine S, Jakubowska T, Jarosz H, et al. The effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer's disease and vascular dementia. J Neurol Sci. 2003;216:119–126
  106. Looi JCL, Sachdev PS. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology. 1999;53:670–678
  107. Malouf R, Birks J. Donepezil for vascular cognitive impairment. Cochrane Database Syst Rev. 2004;(1):CD004395
  108. Mann DM, Yates PO, Marcyniuk B. Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment. Mech Ageing Dev. 1984;25:189–204
  109. Mann DM, Yates PO, Marcyniuk B. The nucleus basalis of Meynert in multi-infarct (vascular) dementia. Acta Neuropathol (Berl). 1986;71:332–337
  110. Marino R. The anterior cerebral artery: I. Anatomo-radiological study of its cortical territories. Surg Neurol. 1976;5:81–87
  111. Martin-Ruiz C, Court J, Lee M, Piggott M, Johnson M, Ballard C, et al. Nicotinic receptors in dementia of Alzheimer. Lewy body and vascular types. Acta Neurol Scand. 2000;176(Suppl.):34–41
  112. Matsuda H. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann Nucl Med. 2001;15:85–92
  113. McAuley MA. Rodent models of focal ischemia. Cerebrovasc Brain Metab Rev. 1995;7:153–180
  114. McBean DE, Kelly PA. Rodent models of global cerebral ischemia: a comparison of two-vessel occlusion and four-vessel occlusion. Gen Pharmacol. 1998;30:431–434
  115. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS–ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–944
  116. Mendez MF, Younesi FL, Perryman KM. Use of donepezil for vascular dementia: preliminary clinical experience. J Neuropsychiatry Clin Neurosci. 1999;11:268–270
  117. Mesulam M, Siddique T, Cohen B. Cholinergic denervation in a pure multi-infarct state: observations on CADASIL. Neurology. 2003;60:1183–1185
  118. Mesulam M. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?. Learn Mem. 2004;11:43–49
  119. Mesulam MM, Geula C. Nucleus basalis (Ch4) and cortical cholinergic innervation of the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J Comp Neurol. 1988;275:216–240
  120. Mesulam MM, Mash D, Hersh L, Bothwell M, Geula C. Cholinergic innervation of the human striatum, globus pallidus, subthalamic nucleus, substantia nigra, and red nucleus. J Comp Neurol. 1992;323:252–268
  121. Mesulam MM, Mufson EJ, Levey AI, Wainer BH. Cholinergic innervation of the cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in rhesus monkey. J Comp Neurol. 1983;214:170–197
  122. Mesulam MM, Shaw P, Mash D, Weintraub S. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol. 2004;55:815–828
  123. Mielke R, Herholz K, Grond M, Kessler J, Heiss WD. Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of associated areas. Dementia. 1994;5:36–41
  124. Moody DM, Bell MA, Challa VR. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. Am J Neuroradiol. 1990;11:431–439
  125. Moretti R, Torre P, Antonello RM, Cazzato G, Bava A. Rivastigmine in subcortical vascular dementia: an open 22-month study. J Neurol Sci. 2002;203–204:141–146
  126. Moretti R, Torre P, Antonello RM, Cazzato G. Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up. Eur J Neurol. 2001;8:361–362
  127. Moroney JT, Bagiella E, Desmond DW, Hachinski VC, Molsa PK, Gustafson L, et al. Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology. 1997;49:1096–1105
  128. Motoike T, Loughna S, Perens E, Román BL, Liao W, Chau TC, et al. Universal GFP reporter for the study of vascular development. Genesis. 2000;28:75–81
  129. Mufson EJ, Bothwell M, Hersh LB, Kordower JH. Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons. J Comp Neurol. 1989;285:196–217
  130. Mufson EJ, Ginsberg SD, Ikonomovic MD, DeKosky ST. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J Chem Neuroanat. 2003;26:233–242
  131. Mufson EJ, Ma SY, Dills J, Cochran EJ, Leurgans S, Wuu J, et al. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol. 2002;443:136–153
  132. Murdoch I, Nicoll JAR, Graham DI, Dewar D. Nucleus basalis of Meynert pathology in the human brain after fatal head injury. J Neurotrauma. 2002;19:279–284
  133. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349:1436–1442
  134. Nakano S, Asada T, Matsuda H, Uno M, Takasaki M. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease. J Nucl Med. 2001;42:1441–1445
  135. Naritomi H. Experimental basis of multi-infarct dementia: memory impairments in rodent models of ischemia. Alzheimer Dis Assoc Disord. 1991;5:103–111
  136. Narumi S, Kiyota Y, Nagaoka A. Cerebral embolization impairs memory function and reduces cholinergic marker enzyme activities in various brain regions in rats. Pharmacol Biochem Behav. 1986;24:1729–1731
  137. Ni JW, Matsumoto K, Li HB, Murakami Y, Watanabe H. Neuronal damage and decrease of central acetylcholine level following permanent occlusion of bilateral common carotid arteries in rat. Brain Res. 1995;673:290–296
  138. O’Brien JT, Erkinjuntti T, Reisberg B, Román G, Sawada T, Pantoni L, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2:89–98
  139. Oda Y, Nakanishi I. The distribution of cholinergic neurons in the human central nervous system. Histol Histopathol. 2000;15:825–834
  140. Ogawa N, Asanuma M, Tanaka K, Hirata H, Kondo Y, Goto M, et al. Long-term time course of regional changes in cholinergic indices following transient ischemia in the spontaneously hypertensive rat brain. Brain Res. 1996;712:60–68
  141. Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thal LJ. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol. 1995;52:702–708
  142. Ordy JM, Thomas GJ, Volpe BT, Dunlap WP, Colombo PM. An animal model of human-type memory loss based on aging, lesion, forebrain ischemia, and drug studies with the rat. Neurobiol Aging. 1988;9:667–683
  143. Pavone F, Fagioli S, Castellano C. Effects of oxotremorine on inhibitory avoidance behaviour in two inbred strains of mice: interaction with 5-methoxy-NN-dimethyltriptamine. Psychopharmacology. 1993;112:249–252
  144. Perry EK, Gibson PH, Blessed G, Perry RH, Tomlinson PE. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci. 1977;34:247–265
  145. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ. 1978;2:1457–1459
  146. Peruzzi P, von Euw D, Lacombe P. Differentiated cerebrovascular effects of physostigmine and tacrine in cortical areas deafferented from the nucleus basalis magnocellularis suggest involvement of basalocortical projections to microvessels. Ann N Y Acad Sci. 2000;903:394–406
  147. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985–1992
  148. Phillips S, Sangalang V, Sterns G. Basal forebrain infarction. Aclinicopathologic correlation. Arch Neurol. 1987;44:1134–1138
  149. Polvikoski T, Sulkava R, Myllykangas L, et al. Prevalence of Alzheimer's disease in very elderly people. A prospective neuropathological study. Neurology. 2001;56:1690–1696
  150. Postiglione A, Lassen NA, Holman BL. Cerebral blood flow in patients with dementia of Alzheimer's type. Aging (Milano). 1993;5:19–26
  151. Price JM, Chi X, Hellermann G, Sutton ET. Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production. Neurol Res. 2001;23:506–512
  152. In:  Pullicino PM,  Caplan LR,  Hommel M editor. Cerebral small artery disease. Advances in neurology. vol. 62:New York: Raven Press; 1993;
  153. Rafael H. Cerebral atherosclerosis and mild Alzheimer's disease. Stroke. 2003;34:e106
  154. Riekse RG, Leverenz JB, McCormick W, Bowen JD, Teri L, Nochlin D, et al. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study. J Am Geriatr Soc. 2004;52:1442–1448
  155. Riley KP, Snowdon DA, Desrosiers MF, Markesbery WR. Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study. Neurobiol Aging. 2005;26:341–347
  156. Rinne JO, Paljarvi L, Rinne UK. Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease. J Neurol Sci. 1987;79:67–76
  157. Roher AE, Esh C, Kokjohn TA, Kalback W, Luehrs DC, Seward JD, et al. Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vasc Biol. 2003;23:2055–2062
  158. Roher AE, Esh C, Rahman A, Kokjohn TA, Beach TG. Atherosclerosis of cerebral arteries in Alzheimer disease. Stroke. 2004;35(11 Suppl. 1):2623–2627
  159. Roher AE, Kuo YM, Potter PE, Emmerling MR, Durham RA, Walker DG, et al. Cortical cholinergic denervation elicits vascular A beta deposition. Ann N Y Acad Sci. 2000;903:366–373
  160. Román GC, Royall DR. A diagnostic dilemma: is “Alzheimer's dementia” Alzheimer's disease, vascular dementia, or both?. Lancet Neurol. 2004;3:141
  161. Román GC, Royall DR. Executive control function: a rational basis for the diagnosis of vascular dementia. Alzheimer Dis Assoc Disord. 1999;13(Suppl. 3):S69–S80
  162. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu GC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS–AIREN International Workshop. Neurology. 1993;43:250–260
  163. Román GC. Brain hypoperfusion: a critical factor in vascular dementia. Neurol Res. 2004;26:454–458
  164. Román GC. Lacunar dementia. In:  Hutton JT,  Kenny AD editor. Senile dementia of the Alzheimer type. New York: Alan R. Liss Inc.; 1985;p. 131–151
  165. Román GC. On the history of lacunes, état criblé, and the white matter lesions of vascular dementia. Cerebrovasc Dis. 2002;13(Suppl. 2):1–6
  166. Román GC. Stroke, cognitive decline and vascular dementia: the silent epidemic of the 21st century. Neuroepidemiology. 2003;22:161–164
  167. Román GC. Vascular dementia revisited: diagnosis, pathogenesis, treatment and prevention. Med Clin North Am. 2002;86:477–499
  168. Román GC. Vascular dementia: distinguishing characteristics, treatment, and prevention. J Am Geriatr Soc. 2003;51(5 Suppl. Dementia):S296–S304
  169. Rosner SS, Rhoton AL, Ono M, Barry M. Microsurgical anatomy of the anterior perforating arteries. J Neurosurg. 1984;61:468–485
  170. Roth M. The natural history of mental disorder in old age. J Ment Sci. 1955;101:281–301
  171. Royall DR, Palmer R, Mulroy A, et al. Pathological determinants of clinical dementia in Alzheimer's disease. Exp Aging Res. 2002;28:143–162
  172. Royall DR. The new “silent” epidemic. J Am Geriatr Soc. 2004;52:1212–1213
  173. Sachdev PS, Brodaty H, Looi JC. Vascular dementia: diagnosis, management and possible prevention. Med J Aust. 1999;170:81–85
  174. Sadoshima S, Ibayashi S, Fujii K, NagaoT , Sugimori H, Fujishima M. Inhibition of acetylcholinesterase modulates the autoregulation of cerebral blood flow and attenuates ischemic brain metabolism in hypertensive rats. J Cereb Blood Flow Metab. 1995;15:845–851
  175. Saito H, Togashi H, Yoshioka M, Nakamura N, Minami M, Parvez H. Animal models of vascular dementia with emphasis on stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1995;22:S257–S259
  176. Sakurada T, Alufuzoff I, Winblad B, Nordberg A. Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia. Brain Res. 1990;521:329–332
  177. Sasaki M, Ehara S, Tamakawa Y, Tohgi H, Sakai A, Mita T. MR anatomy of the substantia innominata and findings in Alzheimer disease: a preliminary report. Am J Neuroradiol. 1995;16:2001–2007
  178. Sassin I, Schultz C, Thai DR, et al. Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol. 2000;100:259–269
  179. Sato A, Sato Y, Uchida S. Activation of the intracerebral cholinergic nerve fibers originating in the basal forebrain increases regional cerebral blood flow in the rat's cortex and hippocampus. Neurosci Lett. 2004;361:90–93
  180. Sato A, Sato Y, Uchida S. Regulation of regional cerebral blood flow by cholinergic fibers originating in the basal forebrain. Int J Dev Neurosci. 2001;19:327–337
  181. Schetinger MR, Bonan CD, Frassetto SS, Wyse AT, Schierholt RC, Webber A, et al. Pre-conditioning to global cerebral ischemia changes hippocampal acetylcholinesterase in the rat. Biochem Mol Biol Int. 1999;47:473–478
  182. Schievink WI, Schaid DJ, Rogers HM, Piepgras DG, Michels VV. On the inheritance of intracranial aneurysms. Stroke. 1994;25:2028–2037
  183. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology. 2004;62:1148–1155
  184. Scremin OU, Li MG, Scremin AM, Jenden DG. Cholinesterase inhibition improves blood flow in the ischemic cerebral cortex. Brain Res Bull. 1997;42:59–70
  185. Selden NR, Gitelman DR, Salamon-Murayama N, Parrish TB, Mesulam MM. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain. 1998;121:2249–2257
  186. Serizawa T, Saeki N, Yamaura A. Microsurgical anatomy and clinical significance of the anterior communicating artery and its perforating branches. Neurosurgery. 1997;40:1211–1216
  187. Shi J, Yang SH, Stubley L, Day AL, Simkins JW. Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res. 2000;853:1–4
  188. Shinotoh H, Namba H, Fukushi K, Nagatsuka S, Tanaka N, Aotsuka A, et al. Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: a positron emission tomography study. Ann Neurol. 2000;48:194–200
  189. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, et al. 15-year longitudinal study on blood pressure and dementia. Lancet. 1996;347:1141–1145
  190. Skoog I, Vanmechelen E, Andreasson LA, Palmertz B, Davidsson P, Hesse C, et al. A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele. Neurodegeneration. 1995;4:433–442
  191. Slotkin TA, Nemeroff CB, Bissette G, Seidler FJ. Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. J Clin Invest. 1994;94:696–702
  192. Smith DE, Roberts J, Gage FH, Tuszynski MH. Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy. Proc Natl Acad Sci USA. 1999;96:10893–10898
  193. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA. 1997;277:813–817
  194. Swartz RH, Black SE. How common is vascular compromise of cholinergic white matter pathways in a memory clinic sample?. J Neurol Sci. 2002;203–204:331
  195. Swartz RH, Sahlas DJ, Black SE. Strategic involvement of cholinergic pathways and executive dysfunction: does location of white matter signal hyperintensities matter?. J Stroke Cerebrovasc Dis. 2003;12:29–36
  196. Takahashi S, Tohgi H, Yonezawa H, Obara S, Yamazaki E. The effect of trihexyphenidyl, an anticholinergic agent, on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease. J Neurol Sci. 1999;167:56–61
  197. Tanaka K, Ogawa N, Mizukawa K, Asanuma M, Kondo Y, Nishibayashi S, et al. Acetylcholinesterase inhibitor ENA-713 protects against ischemia-induced decrease in pre- and postsynaptic cholinergic indices in the gerbil brain following transient ischemia. Neurochem Res. 1994;19:117–122
  198. Thomas A, Ballard C, Kenny RA, O’Brien J, Oakley A, Kalaria R. Correlation of entorhinal amyloid with memory in Alzheimer's and vascular but not Lewy body dementia. Dement Geriatr Cogn Disord. 2005;19:57–60
  199. Togashi H, Kimura S, Matsumoto M, Yoshioka M, Minami M, Saito H. Cholinergic changes in the hippocampus of stroke-prone spontaneously hypertensive rats. Stroke. 1996;27:520–525
  200. Togashi H, Matsumoto M, Yoshioka M, Hirokami M, Minami M, Saito H. Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats. Neurosci Lett. 1994;166:117–120
  201. Tohgi H, Abe T, Kimura M, Saheki M, Takahashi S. Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J Neural Transm. 1996;103:1211–1220
  202. Tohgi H, Yonezawa H, Takahashi S, Sato N, Kato E, Kudo M, et al. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes. Neuroradiology. 1998;40:131–137
  203. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci. 1970;11:205–242
  204. Tomlinson BE, Blessed G, Roth M. Observations on the brains of non-demented old people. J Neurol Sci. 1968;7:331–356
  205. Tong XK, Hamel E. Regional cholinergicdenervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer's disease. Neuroscience. 1999;92:163–175
  206. Uchida S, Suzuki A, Kagitani F, Hotta H. Effects of age on cholinergic vasodilation of cortical cerebral blood vessels in rats. Neurosci Lett. 2000;294:109–112
  207. Van der Staay FJ, Raaijmakers WG, Lammers AJ, Tonnaer JA. Selective fimbria lesions impair acquisition of working and reference memory of rats in a complex spatial discrimination task. Behav Brain Res. 1989;32:151–161
  208. Vennerica A, Shanks MF, Staff RT, Pestell SJ, Forbes KE, Gemmell HG, et al. Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease. Neuroreport. 2002;13:83–87
  209. Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ, Buschke H. Abnormality of gait as a predictor of non-Alzheimer's dementia. N Engl J Med. 2002;347:1761–1768
  210. Vogels OJM, Broere CAJ, ter Laak HJ, ten Donkelaar HJ, Nieuwenhuys R, Schulte BPM. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol Aging. 1990;11:3–13
  211. von Cramon DY, Markowitsch HJ. Human memory dysfunctions due to septal lesions. In:  Numan R editors. The behavioral neuroscience of the septal region. New York: Springer; 2000;p. 380–413
  212. Waller SB, Ball MJ, Reynolds MA, London ED. Muscarinic binding and choline acetyltransferase in postmortem brains of demented patients. Can J Neurol Sci. 1986;13:528–532
  213. Wallin A, Sjögren M, Blennow K, Davidsson P. Decreased cerebrospinal fluid acetylcholinesterase in patients with subcortical vascular dementia. Dement Geriatr Cogn Dis. 2003;16:200–207
  214. Warburton DM. Nicotine as a cognitive enhancer. Prog Neuropsychopharmacol Biol Psychiatry. 1992;16:181–191
  215. Watanabe M, Takeuchi H, Mano K, Watanabe H, Muramoto H. The significance of hypoplasia of the circle of Willis in patients with Binswanger-type cerebrovascular disease. Rinsho Shinkeigaku. 1998;38:102–106[in Japanese]
  216. Weinstein BM, Lawson ND. Arteries, veins, Notch and VEGF. Cold Spring Harbor Symp Quant Biol. 2002;67:155–162
  217. White L, Petrovitch H, Hardman J, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci. 2002;977:9–23
  218. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol. 1981;10:122–126
  219. Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, et al. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology. 2003;61:479–486
  220. Wilkinson IM. Regional cerebral blood flow in man: establishment of “normal” control values and identification of the abnormalities which occur in “stroke” patients. Prog Brain Res. 1972;35:87–103
  221. Yamada S, Ishima T, Hayashi M, Tomita T, Hayashi E. Muscarinic cholinoceptors and choline acetyltransferase activity in the hypothalamus of spontaneously hypertensive rats. Life Sci. 1984;34:2151–2158
  222. Yamamuro Y, Iwano H, Sensui N, Hori K, Nomura M. Acetylcholine in the hippocampus during the discrimination learning performance in a rat model of chronic cerebral ischaemia. Neuroreport. 1996;7:1837–1840
  223. Zekry D, Duyckaerts C, Moulias R, Belmin J, Geoffre C, Herrmann F, et al. Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathol (Berl). 2002;103:481–487
  224. Zekry D, Duyckaerts C, Belmin J, Geoffre C, Herrmann F, Moulias R, et al. The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy. Neurobiol Aging. 2003;24:213–219
  225. Zhang F, Eckman C, Younkin S, Hsiao KK, ladecola C. Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. J Neurosci. 1997;17:7655–7661

PII: S0197-4580(05)00314-3

doi: 10.1016/j.neurobiolaging.2005.10.004

Neurobiology of Aging
Volume 27, Issue 12 , Pages 1769-1785 , December 2006

Article Tools

* Image Usage & Resolution